Generic Name: Lincocin
What is Lincocin?
Escitalopram belongs to a class of drugs known as selective serotonin reuptake inhibitors SSRI. It may improve your energy level and feelings of well-being and decrease nervousness. Read the Medication Guide and, if available, the Patient Information Leaflet provided by your pharmacist before you start taking escitalopram and each time you get a refill.
If you have any questions, ask your doctor or pharmacist. Take this medication by mouth with or without food as directed by your doctor, usually once daily in the morning or evening. The dosage is based on your medical condition, response to treatment, age, and other medications you may be taking. Be sure to tell your doctor and pharmacist about all the products you use including prescription drugs, nonprescription drugs, and herbal products.
Do not use a household spoon because you may not get the correct dose. To reduce your risk of side effects, your doctor may direct you to start taking this drug at a low dose and gradually increase your dose.
Follow your doctor's instructions carefully.
Lexapro has been commercially available in the US since its original launch in 2002, and has been prescribed to more than 18 million US adults for depression, anxiety or both. Lexapro In March 2009, the US Food and Drug Administration FDA approved the supplemental new drug application sNDA of Forest Laboratories for Lexapro escitalopram oxalate indicated for the acute and maintenance treatment of major depressive disorder MDD in adolescents between 12 and 17 years of age.
Lexapro is now only the second antidepressant that is approved for the treatment of MDD in adolescents. MDD affects around two million adolescents in the US. As well as being prescribed for the acute and maintenance treatment of MDD in adults and adolescents, Lexapro is also used for acute treatment of generalised anxiety disorder GAD in adults.
Forest licensed Lexapro from the Danish pharmaceutical company, Lundbeck when the drug was in the clinical stage. Lexapro is also marketed as Cipralex, Seroplex and Seroplexa. The approval of Lexapro by the FDA for the treatment of adolescent depression was based on two placebo-controlled studies. One was conducted in adolescent patients taking Lexapro and the other in children and adolescents taking citalopram.
Lexapro showed statistically significant greater mean improvement from baseline, compared to placebo, on the children's depression rating scale-revised CDRS-R in an eight-week flexible-dose, placebo-controlled study that compared Lexapro 10mg-20mg a day to placebo in 12 to 17-year-old patients reported in 2008.
Children and adolescents aged seven to 17 years old treated with racemic citalopram 20mg-40mg a day showed statistically significant greater mean improvement from baseline on the CDRS-R compared to patients treated with placebo, in another eight-week, flexible-dose, placebo-controlled study. The majority of the positive results for this trial were from the adolescent subgroup. Partly on the basis of the results from this study, the FDA's determination of the effectiveness of Lexapro in the acute treatment of MDD in adolescents was established.
How should I take Lincocin?
Consideration should be given to changing the therapeutic regimen, including possibly discontinuing the medication, in patients whose depression is persistently worse, or who are experiencing emergent suicidality or symptoms that might be precursors to worsening depression or suicidality, especially if these symptoms are severe, abrupt in onset, or were not part of the patient's presenting symptoms.
Families and caregivers of patients being treated with antidepressants for major depressive disorder or other indications, both psychiatric and nonpsychiatric, should be alerted about the need to monitor patients for the emergence of agitation, irritability, unusual changes in behavior, and the other symptoms described above, as well as the emergence of suicidality, and to report such symptoms immediately to health care providers.
Prescriptions for Lexapro should be written for the smallest quantity of tablets consistent with good patient management, in order to reduce the risk of overdose. A major depressive episode may be the initial presentation of bipolar disorder. Whether any of the symptoms described above represent such a conversion is unknown. It should be noted that Lexapro is not approved for use in treating bipolar depression.
What should I avoid while taking Lincocin?
So, whenever the clinical picture includes anxiety cued by specific objects or situations, exposure principles are important to the treatment. Approach: A central issue for most patients with panic disorder is an intense fear of the sensations they experience during a panic attack.
These fears often include catastrophic misperceptions that something terrible may happen during a panic attack such as dying, having a heart attack, experiencing a stroke, fainting, smothering, going crazy or losing control. These "catastrophic misinterpretations" contribute to a "fear of fear" cycle that begins to trigger and intensify attacks in response to benign physiological experiences, like increased heart rate from rushing through the mall.
Though the grave consequences that they fear never occur, patients are not easily convinced that they won't happen the next time.
Lincocin side effects
Lexapro is used to treat major depression, anxiety disorders, panic disorder, obsessive-compulsive disorder, and premenstrual dysphoric disorder. Common side effects of Lexapro include dizziness, headache, insomnia, lightheadedness, drowsiness, nausea, dry mouth, indigestion, heartburn, constipation, diarrhea, changes in weight, and changes in libido sex drive. According to the prescribing information for Lexapro, muscle cramps, stiffness, and weakness have been reported in post-marketing experience.
Post-marketing experience is after the drug has been approved by the U. Food and Drug Administration FDA. During post-marketing experience, patients voluntarily report side effects.
This is different from side effects reported during clinical trials of the drug before it is approved by the FDA. In clinical trials, researchers have tight control over how side effects are reported and can determine whether they are likely related to the drug or not.
Common Lincocin ide effects may include:
Pregnant women and women who are nursing should not take Lexapro.
Weight Changes Patients treated with Lexapro in controlled trials did not differ from placebo-treated patients with regard to clinically important change in body weight.
For them, their Lexapro is simply treating a mild case of anxiety or depression.
Your doctor may suggest a decrease in dosage if you experience side effects that do not go away after approximately 2 weeks.
Patients with these diagnoses were generally excluded from clinical studies during the product's premarketing testing. In subjects with hepatic impairment, clearance of racemic citalopram was decreased and plasma concentrations were increased.
Because escitalopram is extensively metabolized, excretion of unchanged drug in urine is a minor route of elimination.
Where can I get more information?
Patient should be monitored for these symptoms when discontinuing treatment.
The clinical significance of this finding is unknown.